麦澜德: 关于控股股东、实际控制人续签《共同控制协议》及原《一致行动协议》到期解除、部分股东重新签订《一致行动协议》暨权益变动的提示性公告

Core Viewpoint - The announcement details the renewal of the "Joint Control Agreement" and the termination of the original "Consistent Action Agreement" for Nanjing Mailland Medical Technology Co., Ltd, involving key shareholders and their shareholding structure [1][2][11] Group 1: Shareholding Changes - After the equity change, the total direct shareholding of the controlling shareholders and actual controllers, Yang Ruijia and Shi Zhihuai, remains unchanged at 60,595,842 shares, representing 60.60% of the total shares [2][11] - The previous total direct shareholding before the new agreement was 63,173,210 shares, which accounted for 63.17% of the total shares [10][11] Group 2: Agreements and Their Implications - The original "Joint Control Agreement" and "Consistent Action Agreement" were set to expire on August 10, 2025, leading to the renewal of the "Joint Control Agreement" and the signing of a new "Consistent Action Agreement" with some shareholders [2][3][11] - The new "Consistent Action Agreement" includes Yang Ruijia, Shi Zhihuai, Chen Bin, Tu Honglin, Wang Wang, and Zhou Qin, while Zhou Gan did not renew his agreement, thus ending his consistent action relationship with the actual controllers [2][3][11] Group 3: Governance and Management Stability - The renewal of these agreements is expected to stabilize the company's control and ensure continuity in development strategies and management policies, without negatively impacting daily operations or harming the interests of minority investors [11]